Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China · Delayed Price · Currency is CNY 54.83
+6.04 (12.38%)
At close: Aug 4, 2026
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 7.64 billion as of August 4, 2026. Its market cap has increased by 10.25% in one year.
Market Cap
7.64B
Enterprise Value
5.98B
Revenue
453.39M
Ranking
n/a
PE Ratio
185.85
Stock Price
54.83
ChartMarket Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 7.64B, a decrease of -26.79%. That is a compound annual growth rate of -7.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 7.64B | 36.92% |
| Dec 31, 2025 | 5.58B | 34.44% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
| Sep 2, 2022 | 10.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aurisco Pharmaceutical | 8.14B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 8.02B |
| Chengdu Easton Biopharmaceuticals | 7.78B |
| Daan Gene | 7.76B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 7.63B |
| Innovita Biological Technology | 7.53B |
| Acrobiosystems | 7.52B |
| Bio-Thera Solutions | 7.22B |